• 19546 Citations
  • 56 Scopus h-Index
19942019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1994 2019

Filter
Review article
2018
3 Citations (Scopus)

Comment on 2018 American Academy of Neurology guidelines on disease-modifying therapies in MS

Corboy, J. R., Weinshenker, B. G. & Wingerchuk, D. M., Jun 12 2018, In : Neurology. 90, 24, 1 p.

Research output: Contribution to journalReview article

Multiple Sclerosis
Guidelines
Therapeutics
Uncertainty
Consensus
3 Citations (Scopus)

Immune-Mediated Myelopathies

Wingerchuk, D. M., Apr 1 2018, In : CONTINUUM Lifelong Learning in Neurology. 24, 2, Spinal Cord Disorders, p. 497-522 26 p.

Research output: Contribution to journalReview article

Spinal Cord Diseases
Autoantibodies
Differential Diagnosis
Myelitis
Nervous System Trauma
2017
9 Citations (Scopus)

NEDA treatment target? No evident disease activity as an actionable outcome in practice

Parks, N. E., Flanagan, E., Lucchinetti, C. F. & Wingerchuk, D. M., Dec 15 2017, In : Journal of the Neurological Sciences. 383, p. 31-34 4 p.

Research output: Contribution to journalReview article

Multiple Sclerosis
Recurrence
Randomized Controlled Trials
Clinical Trials
Therapeutics
45 Citations (Scopus)

Neuromyelitis Spectrum Disorders

Weinshenker, B. G. & Wingerchuk, D. M., Apr 1 2017, In : Mayo Clinic Proceedings. 92, 4, p. 663-679 17 p.

Research output: Contribution to journalReview article

Neuromyelitis Optica
Aquaporin 4
Multiple Sclerosis
Astrocytes
Autoantibodies
2016
53 Citations (Scopus)

Disease modifying therapies for relapsing multiple sclerosis

Wingerchuk, D. M. & Weinshenker, B. G., 2016, In : BMJ (Online). 354, i3518.

Research output: Contribution to journalReview article

Multiple Sclerosis
Therapeutics
Autoimmune Diseases
Observational Studies
Randomized Controlled Trials
2015
94 Citations (Scopus)

Demographic and clinical features of neuromyelitis optica: A review

Pandit, L., Asgari, N., Apiwattanakul, M., Palace, J., Paul, F., Leite, M. I., Kleiter, I., Chitnis, T., Iorio, R., Würfel, J., Paul, F., Van Pelt, D., Rogier, H., Tedder, T., Saiz, A., Villoslada, P., Levy, M., Pandit, L., Klawiter, E., Weinshenker, B. G. & 30 others, Wingerchuk, D. M., Kim, H. J., Tenembaum, S., Palace, J., Leite, M. I., Apiwattanakul, M., Broadley, S., Prayoonwiwat, N., Kleiter, I., Hellwig, K., Han, M., Banwell, B., Van Herle, K., Jacob, A., Hooper, C., Kazutoshi Sato, D., Nakashima, I., Fujihara, K., Bichuetti, D., Aktas, O., De Seze, J., Yeaman, M., Waubant, E., Zamvil, S., Bennett, J., Smith, T., Lana-Peixoto, M., Asgari, N., Greenberg, B. & Stuve, O., Jun 6 2015, In : Multiple Sclerosis Journal. 21, 7, p. 845-853 9 p.

Research output: Contribution to journalReview article

Neuromyelitis Optica
Demography
Aquaporin 4
Phenotype
Cuba
48 Citations (Scopus)

Update on biomarkers in neuromyelitis optica

GJCFICC&BR, Jan 1 2015, In : Neurology: Neuroimmunology and NeuroInflammation. 2, 4, e134.

Research output: Contribution to journalReview article

Open Access
Neuromyelitis Optica
Biomarkers
Aquaporin 4
Immunoglobulin G
Recurrence